NephroPlus
PublicNephroPlus is now publicly traded
The data on this page reflects NephroPlus's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Dec 10, 2025
Last Round
Series F
May 3, 2024
Est. Valuation at Exit
$240.38M
Total Funding Raised
$314.16M
Company Overview
NephroPlus is a healthcare company that operates a network of dialysis centers providing high-quality and affordable dialysis services, along with treatments for kidney and urological issues through standardized protocols and continuous innovation.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
NephroPlus Comparables
Compare NephroPlus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The Renal Project | 72% | |
| Médica Santa Carmen | 67% | |
| Moolchand Healthcare | 46% | |
NephroPlus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 10, 2025 | ||||
| Series F | May 3, 2024 | ||||
| Debt | Dec 19, 2022 | ||||
| Series E | Dec 13, 2021 | ||||
| Series D | Nov 25, 2019 | ||||
Series C | Aug 24, 2016 |
Key People
Founding team and executive leadership
NephroPlus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCP | Series E |
| Baroda BNP Paribas Mutual Fund | IPO |
| Polar Capital | IPO |
| Prudential Assurance Company | IPO |
| DSP Mutual Fund | IPO |
| Investcorp | IPO, Series F, Series E, Series D |
| International Finance Corporation | Series D, IPO, Series C, Series F, Series B |
NephroPlus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
